🟢 Telix Pharmaceuticals is trading 6.72% up today after announcing proposed US$1.65 billion acquisition of ITM

Telix Pharmaceuticals is trading 6.72% up now at $12.07 after announcing its proposed US$1.65 billion acquisition of ITM Isotope Technologies Munich.

• Reuters reports the transaction includes approximately US$1.25 billion in Telix shares, creating dilution.
• Potential contingent payments are up to US$700 million.
• The deal expands Telix’s radiopharmaceutical supply chain and pipeline, including ITM-11, supporting the company-specific catalyst.